Clinical trial · Observational
A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid Tumor
A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid Tumor : Data Collection and Model Validation
NCT05024331CI-TRIAL-00053850completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to compare and evaluate the predicted values of the participants, and the algorithm predicted values of ANC level reduction periods after high-capacity chemotherapy in pediatric solid tumor patients. The participants are pediatricians who voluntarily participate in this study and consent to this study.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pediatric Solid Tumor | Childhood Solid Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Pediatric physicians
- description
- Assigned Interventions 1. Prediction of the first date of recovery period with given data about chemotherapy of pediatric patients who diagnosed solid tumor at Samsung medical center during 2010-2018 2. Sees the result of the prediction algorithm. 3. Change or maintain their prediction values. 4. Participate in the usability questionnaires.
Primary outcomes (2)
- measure
- accuracy of algorithm
- timeFrame
- This clinical trial is conducted in one day, and the Survey is conducted after completing the test using data from 99 pediatric patients.
- description
- primary outcome is the difference between result of algorithm and prediction values of doctors. total number of pediatric patients who performed chemotherapy and high-capacity chemotherapy at Samsung Medical Center in 2019-2020 - (Exclusion such as insufficient data or death) +10 reliability check questions expected to be approximately 100 questions The test based on data consisting of blood test results from approximately 100 patients, is recorded in anticipation of the first date (recovery date) of a day when ANC levels over 500 last more than 3 days.
- measure
- A quantitative study on usability
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: * physician who is working at Samsung Medical Center as a pediatric doctor * A person who voluntarily agrees to participate in the study Exclusion Criteria: * Those who disagree with the study
References
Publications (0)
Data not yet available
No reference posted for this study.